fda semaglutide mash Novo Nordisk secures approval for Wegovy to treat FDA Approves Semaglutide (Wegovy) Injection

If it becomes severe or bothersome, contact your healthcare provider

Recent studies have reported a possible association between glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and non-arteritic anterior ischemic optic neuropathy (NAION)

This is compared to only 2.4% weight loss in those who only made lifestyle changes

If you find your current schedule isnt working, dont hesitate to adjust

Cardiovascular: MACE reduction, endothelial function, and cardiac metabolic health studies

Among subjects who began semaglutide treatment at least two years before the end of study period and showed high adherence to treatment, HbA1c was reduced by 0.76% after 24 months and by 0.43% after 36 months